GSK asks US patent of­fice to refuse Mod­er­na’s ‘Covid Mvax’ trade­mark reg­is­tra­tion as 'too gener­ic'

Be­fore there were Covid-19 vac­cines, there were trade­marked names for Covid-19 vac­cines. The phar­ma com­pa­nies work­ing fast and fu­ri­ous­ly on the sci­en­tif­ic dis­cov­er­ies in 2020 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.